

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb40479</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Molecular Mechanisms of Anti-inflammatory Activities of the Extracts of Ocimum gratissimum and Thymus vulgaris</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Francis Olaoye</surname><given-names>Ige</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Joseph Oso</surname><given-names>Babatunde</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Aberuagba</surname><given-names>Adepeju</given-names></name></contrib></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>13</volume>
      <issue>4</issue>
      <fpage>207</fpage>
      <lpage>216</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>1</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>5</month>
          <year>2021</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; A large body of literature suggests that the extracts of &lt;em&gt;Ocimum gratissimum (&lt;/em&gt;&lt;em&gt;O&lt;/em&gt;. &lt;em&gt;gratissimum) &lt;/em&gt;and &lt;em&gt;Thymus vulgaris&lt;/em&gt; (&lt;em&gt;T&lt;/em&gt;. &lt;em&gt;vulgaris&lt;/em&gt;) play protective roles against various inflammatory disorders. However, the possible mechanism of action with reference to the interactions of their respective phytochemical compositions with pro-inflammatory mediators as the indication of their therapeutic effects is less clear. Therefore, the immunomodulatory properties of &lt;em&gt;O&lt;/em&gt;. &lt;em&gt;gratissimum&lt;/em&gt; and &lt;em&gt;T&lt;/em&gt;. &lt;em&gt;vulgaris &lt;/em&gt;were investigated in this study. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The &lt;em&gt;in vitro&lt;/em&gt; lipoxygenase inhibitory potentials of methanolic extracts of the selected plants were assessed through colorimetric analysis. The pharmacokinetics of some identified compounds in the botanicals were investigated via the Swiss ADME server while the molecular interactions of the compounds with lipoxygenase, IL-1, IL-6, TNF-&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&amp;alpha;, IL-8, and CCL-2 were performed through molecular docking. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The assessment&lt;em&gt; &lt;/em&gt;of the lipoxygenase inhibition revealed the extracts could possess anti-inflammatory agents. The pharmacokinetic results of some selected compounds identified in the botanicals showed moderate toxic effects compared to indomethacin. The molecular docking study substantiated the report of the &lt;em&gt;in vitro&lt;/em&gt; analysis as indicated in the binding score of all the selected compounds compared to indomethacin. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The phytochemical components of the extracts of &lt;em&gt;O. gratissimum &lt;/em&gt;and &lt;em&gt;T. vulgaris&lt;/em&gt; could be effective as anti-inflammatory agents that could be explored in preventing disorders associated with excessive activities of pro-inflammatory mediators.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
